Literature DB >> 20237948

Multifocal community-acquired necrotizing fasciitis caused by a Panton-Valentine leukocidin-producing methicillin-sensitive Staphylococcus aureus.

S Perbet1, A Soummer, C Vinsonneau, A Vandebrouck, T Rackelboom, J Etienne, A Cariou, J-D Chiche, J-P Mira, J Charpentier.   

Abstract

We describe a rare case of multifocal necrotizing fasciitis (NF) complicating a single vaccine injection. Injection of hepatitis B vaccine of a 16-year-old immunocompetent woman developed into rapidly spreading multifocal NF of the right arm and the thighs, with septic shock. Treatment with antimicrobial therapy and surgical debridements allowed amputation to be avoided with a favourable outcome. The etiological agent was a methicillin-sensitive Staphylococcus aureus (MSSA) isolate harboring the Panton-Valentine leukocidin (PVL) and five enterotoxins. PVL has recently been reported in large series of methicillin-resistant SA cases and has been associated with necrotizing infections. Some strains of MSSA could harbor PVL and enterotoxins. PCR investigation is not frequent but could improve the understanding of the mechanisms of lesions. This case is in keeping with the increasing incidence of MSSA harboring PVL and enterotoxins with multifocal dissemination NF and emphasizes the necessary precautions for skin decontamination before vaccine injection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20237948     DOI: 10.1007/s15010-010-0002-7

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  11 in total

1.  Facial necrotizing fasciitis in an infant caused by a five toxin-secreting methicillin-susceptible Staphylococcus aureus.

Authors:  Delphine Gerard; Patricia Mariani-Kurkdjian; Philippe Sachs; Dominique Berrebi; Thierry Van-Den-Abbeele; Stéphane Dauger
Journal:  Intensive Care Med       Date:  2009-01-21       Impact factor: 17.440

2.  Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles.

Authors:  Loren G Miller; Francoise Perdreau-Remington; Gunter Rieg; Sheherbano Mehdi; Josh Perlroth; Arnold S Bayer; Angela W Tang; Tieu O Phung; Brad Spellberg
Journal:  N Engl J Med       Date:  2005-04-07       Impact factor: 91.245

3.  Recurrent necrotizing fasciitis caused by methicillin-resistant Staphylococcus aureus.

Authors:  C-H Wong; S-H Tan; A Kurup; A B-H Tan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-11-13       Impact factor: 3.267

4.  Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients.

Authors:  Yves Gillet; Bertrand Issartel; Philippe Vanhems; Jean-Christophe Fournet; Gerard Lina; Michèle Bes; François Vandenesch; Yves Piémont; Nicole Brousse; Daniel Floret; Jerome Etienne
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

5.  Rapidly progressive necrotizing fasciitis caused by Staphylococcus aureus.

Authors:  Yu-Tsung Lee; Trong-Duo Chou; Ming-Yieh Peng; Feng-Yee Chang
Journal:  J Microbiol Immunol Infect       Date:  2005-10       Impact factor: 4.399

6.  Staphylococcus aureus Panton-Valentine leukocidin targets muscle tissues in a child with myositis and necrotizing fasciitis.

Authors:  Deborah Lehman; Ching Wen Tseng; Samantha Eells; Loren G Miller; Xuemo Fan; David O Beenhouwer; George Y Liu
Journal:  Clin Infect Dis       Date:  2010-01-01       Impact factor: 9.079

7.  Clindamycin-induced suppression of toxic-shock syndrome--associated exotoxin production.

Authors:  P M Schlievert; J A Kelly
Journal:  J Infect Dis       Date:  1984-03       Impact factor: 5.226

8.  Necrotizing fasciitis due to a methicillin-sensitive Staphylococcus aureus isolate harboring an enterotoxin gene cluster.

Authors:  William R Morgan; Michael D Caldwell; Jennifer M Brady; Mary E Stemper; Kurt D Reed; Sanjay K Shukla
Journal:  J Clin Microbiol       Date:  2006-12-13       Impact factor: 5.948

9.  The current spectrum of Staphylococcus aureus infection in a tertiary care hospital.

Authors:  D M Musher; N Lamm; R O Darouiche; E J Young; R J Hamill; G C Landon
Journal:  Medicine (Baltimore)       Date:  1994-07       Impact factor: 1.889

10.  Staphylococcus aureus isolates associated with necrotizing pneumonia bind to basement membrane type I and IV collagens and laminin.

Authors:  Sophie de Bentzmann; Anne Tristan; Jerome Etienne; Nicole Brousse; Francois Vandenesch; Gerard Lina
Journal:  J Infect Dis       Date:  2004-09-15       Impact factor: 5.226

View more
  5 in total

1.  Simulated antibiotic exposures in an in vitro hollow-fiber infection model influence toxin gene expression and production in community-associated methicillin-resistant Staphylococcus aureus strain MW2.

Authors:  Solen Pichereau; Madhulatha Pantrangi; William Couet; Cedric Badiou; Gerard Lina; Sanjay K Shukla; Warren E Rose
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

2.  Serious life-threatening multifocal infection in a child, caused by Panton-Valentine leucocidin-producing Staphylococcus aureus (PVL-MSSA).

Authors:  Neda Irenji; Suresh Kumar Gopala Pillai; Jennifer Susan West-Jones
Journal:  BMJ Case Rep       Date:  2018-06-05

3.  Molecular characterization and panton-valentine leucocidin typing of community-acquired methicillin-sensitive Staphylococcus aureus clinical isolates.

Authors:  Kome Otokunefor; Tim Sloan; Angela M Kearns; Richard James
Journal:  J Clin Microbiol       Date:  2012-06-20       Impact factor: 5.948

4.  Synchronous multifocal necrotizing fasciitis prognostic factors: a retrospective case series study in a single center.

Authors:  Ching-Yu Lee; Yen-Yao Li; Tsan-Wen Huang; Tsung-Yu Huang; Wei-Hsiu Hsu; Yao-Hung Tsai; Jou-Chen Huang; Kuo-Chin Huang
Journal:  Infection       Date:  2016-10-24       Impact factor: 3.553

5.  Towards Understanding COVID-19: Molecular Insights, Co-infections, Associated Disorders, and Aging.

Authors:  Elena L Paley
Journal:  J Alzheimers Dis Rep       Date:  2021-07-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.